{
    "medicine_id": "413aa8bd9aa3cf92fa7da0140b079e4b99f91f0c",
    "platform_id": "DB01294",
    "metadata": {
        "name": "7 Select Pink Bismuth 1050 mg 30mL Suspension",
        "composition": "1050 mg 30mL Bismuth subsalicylate",
        "clinical_particulars": {
            "therapeutic_indications": "Used to treat nausea heartburn indigestion upset stomach diarrhea and other temporary discomforts of the stomach and gastrointestinal tract",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Bismuth subsalicylate displays anti inflammatory action due to salicylic acid and also acts as an antacid and mild antibiotic It can also cause a black tongue and black stools in some users of the drug when it combines with trace amounts of sulfur in their saliva and gastrointestinal tract This discoloration is temporary and harmless",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06767",
                        "description": "The serum concentration of Bismuth subsalicylate can be increased when it is combined with Ammonium chloride"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "Ginkgo biloba may increase the anticoagulant activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The serum concentration of Methotrexate can be increased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The serum concentration of Pralatrexate can be increased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The therapeutic efficacy of Probenecid can be decreased when used in combination with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of bleeding can be increased when Treprostinil is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The serum concentration of Doxycycline can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00256",
                        "description": "The serum concentration of Lymecycline can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00453",
                        "description": "The serum concentration of Clomocycline can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00595",
                        "description": "The serum concentration of Oxytetracycline can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00618",
                        "description": "The serum concentration of Demeclocycline can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "The serum concentration of Tetracycline can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00931",
                        "description": "The serum concentration of Metacycline can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "The serum concentration of Minocycline can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Sarecycline can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Omadacycline can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13264",
                        "description": "The serum concentration of Penimepicycline can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of bleeding and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Ketoprofen"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of bleeding and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Dexketoprofen"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of Phenindione"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of Coumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "Bismuth subsalicylate may increase the anticoagulant activities of S Warfarin"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "The serum concentration of Acetyldigitoxin can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "The serum concentration of Deslanoside can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "The serum concentration of Ouabain can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The serum concentration of Digitoxin can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "The serum concentration of Oleandrin can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "The serum concentration of Cymarin can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "The serum concentration of Proscillaridin can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The serum concentration of Metildigoxin can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "The serum concentration of Lanatoside C can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "The serum concentration of Gitoformate can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The serum concentration of Acetyldigoxin can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "The serum concentration of Peruvoside can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The metabolism of Tioguanine can be decreased when combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The metabolism of Azathioprine can be decreased when combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The metabolism of Mercaptopurine can be decreased when combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB09275",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Bismuth subcitrate potassium"
                    },
                    {
                        "drugbank-id": "DB11281",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Bismuth subcarbonate"
                    },
                    {
                        "drugbank-id": "DB13209",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Bismuth subgallate"
                    },
                    {
                        "drugbank-id": "DB13910",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Valproate bismuth"
                    },
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Lepirudin"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Bivalirudin"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Alteplase"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Urokinase"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Reteplase"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Anistreplase"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Tenecteplase"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Abciximab"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Drotrecogin alfa"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Streptokinase"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Argatroban"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ardeparin"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Fondaparinux"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Pentosan polysulfate"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Dipyridamole"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Iloprost"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Heparin"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Enoxaparin"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ximelagatran"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Desmoteplase"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Defibrotide"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ancrod"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Beraprost"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Fibrinolysin"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Prasugrel"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Rivaroxaban"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Sulodexide"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Semuloparin"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Idraparinux"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Cangrelor"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Astaxanthin"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Apixaban"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Otamixaban"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Amediplase"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Dabigatran etexilate"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Danaparoid"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Dalteparin"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Tinzaparin"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Nadroparin"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Triflusal"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ditazole"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Edoxaban"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Potassium citrate"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Sodium citrate"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Dextran"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Bemiparin"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Parnaparin"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Desirudin"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Zinc citrate"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Antithrombin Alfa"
                    },
                    {
                        "drugbank-id": "DB11312",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Protein C"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Antithrombin III human"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Letaxaban"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Darexaban"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Betrixaban"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Monteplase"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Gabexate"
                    },
                    {
                        "drugbank-id": "DB13149",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Brinase"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Melagatran"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Saruplase"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Edetate calcium disodium anhydrous"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Dabigatran"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Troxerutin"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Edetic acid"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Reviparin"
                    },
                    {
                        "drugbank-id": "DB00030",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Insulin human"
                    },
                    {
                        "drugbank-id": "DB00046",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Insulin lispro"
                    },
                    {
                        "drugbank-id": "DB00047",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Insulin glargine"
                    },
                    {
                        "drugbank-id": "DB00071",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Insulin pork"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Troglitazone"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Glimepiride"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Acarbose"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Metformin"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Sulfadiazine"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00414",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Acetohexamide"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Quinine"
                    },
                    {
                        "drugbank-id": "DB00491",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Miglitol"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Chlorpropamide"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Nateglinide"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Tolazamide"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Repaglinide"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Phenformin"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Glyburide"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Glipizide"
                    },
                    {
                        "drugbank-id": "DB01120",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Gliclazide"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Tolbutamide"
                    },
                    {
                        "drugbank-id": "DB01132",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Pioglitazone"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01251",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Gliquidone"
                    },
                    {
                        "drugbank-id": "DB01252",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Mitiglinide"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Sitagliptin"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Sunitinib"
                    },
                    {
                        "drugbank-id": "DB01276",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Exenatide"
                    },
                    {
                        "drugbank-id": "DB01277",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Mecasermin"
                    },
                    {
                        "drugbank-id": "DB01278",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Pramlintide"
                    },
                    {
                        "drugbank-id": "DB01289",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Glisoxepide"
                    },
                    {
                        "drugbank-id": "DB01306",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Insulin aspart"
                    },
                    {
                        "drugbank-id": "DB01307",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Insulin detemir"
                    },
                    {
                        "drugbank-id": "DB01309",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Insulin glulisine"
                    },
                    {
                        "drugbank-id": "DB01382",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Glymidine"
                    },
                    {
                        "drugbank-id": "DB01700",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of AICA ribonucleotide"
                    },
                    {
                        "drugbank-id": "DB04830",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Buformin"
                    },
                    {
                        "drugbank-id": "DB04876",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Vildagliptin"
                    },
                    {
                        "drugbank-id": "DB04878",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Voglibose"
                    },
                    {
                        "drugbank-id": "DB05115",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of NN344"
                    },
                    {
                        "drugbank-id": "DB05819",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of NBI 6024"
                    },
                    {
                        "drugbank-id": "DB06011",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of AMG 222"
                    },
                    {
                        "drugbank-id": "DB06127",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Bisegliptin"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Alogliptin"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Dapagliflozin"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Saxagliptin"
                    },
                    {
                        "drugbank-id": "DB06655",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Liraglutide"
                    },
                    {
                        "drugbank-id": "DB08382",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Gosogliptin"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08962",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Glibornuride"
                    },
                    {
                        "drugbank-id": "DB09022",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Benfluorex"
                    },
                    {
                        "drugbank-id": "DB09038",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Empagliflozin"
                    },
                    {
                        "drugbank-id": "DB09043",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Albiglutide"
                    },
                    {
                        "drugbank-id": "DB09045",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Dulaglutide"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Lobeglitazone"
                    },
                    {
                        "drugbank-id": "DB09199",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Netoglitazone"
                    },
                    {
                        "drugbank-id": "DB09200",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Rivoglitazone"
                    },
                    {
                        "drugbank-id": "DB09201",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Ciglitazone"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Lixisenatide"
                    },
                    {
                        "drugbank-id": "DB09456",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Insulin beef"
                    },
                    {
                        "drugbank-id": "DB09564",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Insulin degludec"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Insulin peglispro"
                    },
                    {
                        "drugbank-id": "DB11568",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Insulin tregopil"
                    },
                    {
                        "drugbank-id": "DB11698",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Ipragliflozin"
                    },
                    {
                        "drugbank-id": "DB11723",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Dutogliptin"
                    },
                    {
                        "drugbank-id": "DB11780",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Allicin"
                    },
                    {
                        "drugbank-id": "DB11824",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Tofogliflozin"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Ertugliflozin"
                    },
                    {
                        "drugbank-id": "DB11898",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of 2 4 thiazolidinedione"
                    },
                    {
                        "drugbank-id": "DB11950",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Teneligliptin"
                    },
                    {
                        "drugbank-id": "DB11992",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Omarigliptin"
                    },
                    {
                        "drugbank-id": "DB12268",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Carmegliptin"
                    },
                    {
                        "drugbank-id": "DB12412",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Gemigliptin"
                    },
                    {
                        "drugbank-id": "DB12417",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Anagliptin"
                    },
                    {
                        "drugbank-id": "DB12625",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Evogliptin"
                    },
                    {
                        "drugbank-id": "DB12713",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Sotagliflozin"
                    },
                    {
                        "drugbank-id": "DB12781",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Balaglitazone"
                    },
                    {
                        "drugbank-id": "DB12935",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Remogliflozin etabonate"
                    },
                    {
                        "drugbank-id": "DB13406",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Carbutamide"
                    },
                    {
                        "drugbank-id": "DB13446",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Guar gum"
                    },
                    {
                        "drugbank-id": "DB13675",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Metahexamide"
                    },
                    {
                        "drugbank-id": "DB13928",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Semaglutide"
                    },
                    {
                        "drugbank-id": "DB14027",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Taspoglutide"
                    },
                    {
                        "drugbank-id": "DB14035",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Englitazone"
                    },
                    {
                        "drugbank-id": "DB15171",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Tirzepatide"
                    },
                    {
                        "drugbank-id": "DB15217",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Gastric inhibitory polypeptide"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Ramipril"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Fosinopril"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Benazepril"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Enalapril"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Moexipril"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Lisinopril"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Perindopril"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Quinapril"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Omapatrilat"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Rescinnamine"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Captopril"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Spirapril"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Temocapril"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Imidapril"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Delapril"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14209",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Trandolaprilat"
                    },
                    {
                        "drugbank-id": "DB14210",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Moexiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Quinoline Yellow WS"
                    },
                    {
                        "drugbank-id": "DB15565",
                        "description": "The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Cilazaprilat"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Torasemide"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Bumetanide"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Etacrynic acid"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Piretanide"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Azosemide"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Ethoxzolamide"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Methazolamide"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Acetazolamide"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Diclofenamide"
                    },
                    {
                        "drugbank-id": "DB00233",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Aminosalicylic acid is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Salicylic acid is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Olsalazine is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB06251",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Dersalazine"
                    },
                    {
                        "drugbank-id": "DB06807",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Phenyl aminosalicylate"
                    },
                    {
                        "drugbank-id": "DB09543",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13509",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Aloxiprin"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Guacetisal"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Carbaspirin calcium"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Choline salicylate"
                    },
                    {
                        "drugbank-id": "DB14026",
                        "description": "The risk or severity of bleeding nephrotoxicity and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Thiosalicylic acid"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The serum concentration of Valproic acid can be increased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Icosapent"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Mesalazine"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Nabumetone"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Ketorolac"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Tenoxicam"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Tolmetin"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Piroxicam"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Fenoprofen"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Diclofenac"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Sulindac"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Flurbiprofen"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Etodolac"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Mefenamic acid"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Naproxen"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Sulfasalazine"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Phenylbutazone"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Meloxicam"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Carprofen"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Diflunisal"
                    },
                    {
                        "drugbank-id": "DB00870",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Suprofen"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Meclofenamic acid"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Acetylsalicylic acid"
                    },
                    {
                        "drugbank-id": "DB00963",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Bromfenac"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Oxaprozin"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Balsalazide"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Magnesium salicylate"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Salsalate"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Choline magnesium trisalicylate"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Antrafenine"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Antipyrine"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Tiaprofenic acid"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Lornoxicam"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Aceclofenac"
                    },
                    {
                        "drugbank-id": "DB06802",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Nepafenac"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Dexibuprofen"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Droxicam"
                    },
                    {
                        "drugbank-id": "DB11079",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Trolamine salicylate"
                    },
                    {
                        "drugbank-id": "DB13346",
                        "description": "The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Bufexamac"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of bleeding can be increased when Diltiazem is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The risk or severity of bleeding can be increased when Verapamil is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The serum concentration of Flunisolide can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The serum concentration of Betamethasone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The serum concentration of Triamcinolone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The serum concentration of Prednisone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The serum concentration of Fludrocortisone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The serum concentration of Hydrocortisone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The serum concentration of Prednisolone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The serum concentration of Methylprednisolone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The serum concentration of Trilostane can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The serum concentration of Budesonide can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The serum concentration of Dexamethasone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The serum concentration of Corticotropin can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The serum concentration of Cortisone acetate can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The serum concentration of Paramethasone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The serum concentration of Aldosterone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The serum concentration of Fluprednisolone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The serum concentration of Meprednisone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The serum concentration of Melengestrol can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The serum concentration of Deflazacort can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The serum concentration of Cortivazol can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The serum concentration of Prednylidene can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The serum concentration of Cloprednol can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The serum concentration of Cortisone can be decreased when it is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00063",
                        "description": "The risk or severity of bleeding can be increased when Eptifibatide is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The risk or severity of bleeding can be increased when Ticlopidine is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The risk or severity of bleeding can be increased when Clopidogrel is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "The risk or severity of bleeding can be increased when Tirofiban is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The risk or severity of bleeding can be increased when Pentoxifylline is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of bleeding can be increased when Cilostazol is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01207",
                        "description": "The risk or severity of bleeding can be increased when Ridogrel is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of bleeding can be increased when Sevoflurane is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The risk or severity of bleeding can be increased when Resveratrol is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of bleeding can be increased when Nimesulide is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The risk or severity of bleeding can be increased when Tesmilifene is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of bleeding can be increased when Ibudilast is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB05767",
                        "description": "The risk or severity of bleeding can be increased when Andrographolide is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of bleeding can be increased when Caplacizumab is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of bleeding can be increased when Tranilast is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB08887",
                        "description": "The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "The risk or severity of bleeding can be increased when Trapidil is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of bleeding can be increased when Naftopidil is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of bleeding can be increased when Sarpogrelate is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB12321",
                        "description": "The risk or severity of bleeding can be increased when Ifetroban is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of bleeding can be increased when Nitroaspirin is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of bleeding can be increased when Ketanserin is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of bleeding can be increased when Indobufen is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB12749",
                        "description": "The risk or severity of bleeding can be increased when Butylphthalide is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB12771",
                        "description": "The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13036",
                        "description": "The risk or severity of bleeding can be increased when Ramatroban is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13327",
                        "description": "The risk or severity of bleeding can be increased when Picotamide is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13367",
                        "description": "The risk or severity of bleeding can be increased when Cloricromen is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "The risk or severity of bleeding can be increased when Linsidomine is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of bleeding can be increased when Buflomedil is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB13929",
                        "description": "The risk or severity of bleeding can be increased when Relcovaptan is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB10076",
                        "description": "The risk or severity of adverse effects can be increased when Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB10342",
                        "description": "The risk or severity of adverse effects can be increased when Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB10600",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A California 7 2009 X 181 H1N1 antigen propiolactone inactivated is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB10794",
                        "description": "The risk or severity of adverse effects can be increased when Influenza B virus B Brisbane 60 2008 antigen formaldehyde inactivated is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB10990",
                        "description": "The risk or severity of adverse effects can be increased when Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB11038",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A Brisbane 59 2007 H1N1 hemagglutinin antigen propiolactone inactivated is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB11040",
                        "description": "The risk or severity of adverse effects can be increased when Influenza B virus B Brisbane 60 2008 hemagglutinin antigen propiolactone inactivated is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB11041",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A California 7 2009 X 181 H1N1 hemagglutinin antigen propiolactone inactivated is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB11044",
                        "description": "The risk or severity of adverse effects can be increased when Influenza B virus B Brisbane 60 2008 antigen propiolactone inactivated is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB14384",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A Victoria 210 2009 X 187 H3N2 hemagglutinin antigen formaldehyde inactivated is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB14385",
                        "description": "The risk or severity of adverse effects can be increased when Influenza B virus B Brisbane 60 2008 hemagglutinin antigen formaldehyde inactivated is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB14394",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A California 7 2009 H1N1 live attenuated antigen is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB14445",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A Victoria 210 2009 X 187 H3N2 antigen formaldehyde inactivated is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB14449",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A Perth 16 2009 H3N2 live attenuated antigen is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB14619",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A Uruguay 716 2007 H3N2 antigen propiolactone inactivated is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB14620",
                        "description": "The risk or severity of adverse effects can be increased when Influenza A virus A Brisbane 59 2007 H1N1 antigen propiolactone inactivated is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "The serum concentration of Bismuth subsalicylate can be increased when it is combined with Monopotassium phosphate"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Varicella Zoster Vaccine Live attenuated"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Cyclosporine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "Succinylcholine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Reserpine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "Ziprasidone may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00260",
                        "description": "Cycloserine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "Amitriptyline may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "Protriptyline may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "Vinorelbine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "Clozapine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Thiethylperazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "Sulpiride may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "Loxapine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "Remoxipride may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "Promazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "Prochlorperazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "Teniposide may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "Imipramine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Chlorpromazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "Haloperidol may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Triflupromazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "Cyclophosphamide may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "Nortriptyline may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "Vincristine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "Amoxapine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "Fluphenazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00649",
                        "description": "Stavudine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "Thioridazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Moricizine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "Trimipramine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "Risperidone may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "Trifluoperazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "Perphenazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "Flupentixol may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Ethanol may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "Cyclobenzaprine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "Mesoridazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "Acetophenazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Promethazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "Pimozide may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Doxepin may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "Desipramine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "Clindamycin may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "Tubocurarine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "Paclitaxel may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "Aripiprazole may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "Chlorprothixene may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "Clomipramine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "Decamethonium may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "Alimemazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "Paliperidone may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB01598",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Imipenem"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Periciazine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Molindone"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Thiothixene"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB01627",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Lincomycin"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Amineptine"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Osanetant"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Bifeprunox"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Pimavanserin"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of BL 1020"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Sertindole"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Asenapine"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Amisulpride"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Perospirone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Amperozide"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Dosulepin"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Melperone"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Zotepine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Methylene blue"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Tianeptine"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Azaperone"
                    },
                    {
                        "drugbank-id": "DB11537",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Pirlimycin"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Raclopride"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Ritanserin"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Perazine"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Benperidol"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Opipramol"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Tiapride"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Sultopride"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Melitracen"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Iprindole"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Veralipride"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Gallamine"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB00781",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Polymyxin B"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Penfluridol"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Neomycin may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB06827",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Viomycin"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00024",
                        "description": "The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "The therapeutic efficacy of Liothyronine can be increased when used in combination with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The therapeutic efficacy of Levothyroxine can be increased when used in combination with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The therapeutic efficacy of Liotrix can be increased when used in combination with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB03604",
                        "description": "The therapeutic efficacy of Tiratricol can be increased when used in combination with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB09100",
                        "description": "The therapeutic efficacy of Thyroid porcine can be increased when used in combination with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The risk or severity of adverse effects can be increased when Acetaminophen is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of adverse effects can be increased when Propacetamol is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Furosemide"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The protein binding of Phenytoin can be decreased when combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The protein binding of Fosphenytoin can be decreased when combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB00869",
                        "description": "The risk or severity of metabolic acidosis can be increased when Dorzolamide is combined with Bismuth subsalicylate"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}